azacitidine has been researched along with Rhabdoid Tumor in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiyokawa, N; Nakasato, K; Okita, H; Ueno-Yokohata, H | 1 |
| da Costa, MJG; Ebinger, M; Frühwald, MC; Gerss, J; Hasselblatt, M; Hauser, P; Hettmer, S; Jakob, M; Johann, P; Kerl, K; Kröncke, T; Nemes, K; Reinhard, H; Schüller, U; Sehested, A; Siebert, R; Steinbügl, M; Sumerauer, D; Tüchert, S; Witt, O | 1 |
| Borchardt, C; Clemens, D; Dirksen, U; Frühwald, MC; Kool, M; Unland, R | 1 |
| Kato, H; Koshida, S; Narita, T; Ohta, S; Sugita, K; Taga, T; Takeuchi, Y | 1 |
| Frühwald, MC; Grotzer, M; Hagemann, C; Jürgens, H; Mühlisch, J; Osada, N; Rickert, CH; Roggendorf, W; Schwering, A; Sörensen, N; Vince, GH | 1 |
5 other study(ies) available for azacitidine and Rhabdoid Tumor
| Article | Year |
|---|---|
Hypermethylation of RASSF1A gene in pediatric rhabdoid tumor of the kidney and clear cell sarcoma of the kidney.
Topics: Azacitidine; Cell Line, Tumor; Child; Decitabine; DNA Methylation; Humans; Kidney; Kidney Neoplasms; Nephroma, Mesoblastic; Rhabdoid Tumor; Sarcoma, Clear Cell; Tumor Suppressor Proteins | 2023 |
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Decitabine; Humans; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rhabdoid Tumor | 2021 |
Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; Decitabine; Doxorubicin; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Rhabdoid Tumor; Vorinostat | 2015 |
Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: differentiation-induction using 5-azacytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Biomarkers; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Female; Gene Expression; Humans; Immunohistochemistry; Infant; Male; Mesangial Cells; Muscle, Skeletal; Muscle, Smooth; Neuroectodermal Tumors, Primitive, Peripheral; Pericytes; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Rhabdoid Tumor; RNA, Messenger | 2003 |
Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.
Topics: Adolescent; Adult; Azacitidine; Brain Neoplasms; Caspase 8; Caspases; Child; Child, Preschool; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Silencing; Humans; Hydroxamic Acids; Infant; Male; Neuroectodermal Tumors, Primitive; Promoter Regions, Genetic; Rhabdoid Tumor; Teratoma; Tumor Suppressor Proteins | 2006 |